BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 9781962)

  • 1. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
    Chang AE; Karnell LH; Menck HR
    Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
    Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
    Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis.
    Bishop KD; Olszewski AJ
    Int J Cancer; 2014 Jun; 134(12):2961-71. PubMed ID: 24272143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of noncutaneous melanomas in the U.S.
    McLaughlin CC; Wu XC; Jemal A; Martin HJ; Roche LM; Chen VW
    Cancer; 2005 Mar; 103(5):1000-7. PubMed ID: 15651058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient characteristics, methods of diagnosis and treatment of melanoma in the United States.
    Sutherland CM; Chmiel JS; Henson DE; Cunningham MP; Peace BB; Winchester DP
    Surg Gynecol Obstet; 1992 Aug; 175(2):129-34. PubMed ID: 1636137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of brain metastases in cutaneous head and neck melanoma.
    Daryanani D; Plukker JT; de Jong MA; Haaxma-Reiche H; Nap R; Kuiper H; Hoekstra HJ
    Melanoma Res; 2005 Apr; 15(2):119-24. PubMed ID: 15846145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracutaneous Melanoma.
    Carvajal R; Maniar R
    Hematol Oncol Clin North Am; 2021 Feb; 35(1):85-98. PubMed ID: 33759775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
    Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
    Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated statistical data for malignant melanoma in Japan.
    Ishihara K; Saida T; Yamamoto A;
    Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
    Schaefer T; Satzger I; Gutzmer R
    Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous melanoma: prognosis and treatment results worldwide.
    Balch CM
    Semin Surg Oncol; 1992; 8(6):400-14. PubMed ID: 1439450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
    Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
    Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
    Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
    Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
    Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the studies of etiology, epidemiology and pathogenesis of ocular melanomas.
    Hu D; McCormick SA
    Eye Sci; 2011 Mar; 26(1):18-22. PubMed ID: 21425491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.